3rd Quarter - Amendment

ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.) for ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$332,112
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2019 $946,258 Replaced
3rd Quarter - Amendment (this page) Feb 3, 2020 $332,112 Replaced
3rd Quarter - Amendment Sep 23, 2020 $287,469 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Behavioral health and opioids; Value-based health care; Transparency in health care billing; Violence and trauma prevention; treatment, and funding; Maternal mortality; 340B drug pricing program; Health care innovation; Digital health; Drug pricing; Drug Shortages; Access to care; Preserving the Affordable Care Act protections; Surprise billing; H.R. 965 CREATES Act of 2019; H.R. 1897, MOMMA'S Act; Maternal Morbidity; HR 1897/S. 916 Mothers and Offspring Mortality and Morbidity Awareness Act.

LobbyistCovered position, as disclosed
MEGHAN CLUNE WOLTMAN —
ANTHONY CURRY —
SHAUNA GARDNER —
JOYCE ROGERS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 916 (116th), H.R. 1897 (116th), H.R. 965 (116th)

Medicare/Medicaid MMM

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Oppose Site Neutral Cust and 340B Cuts; Medicaid Funding; Health Care Innovation; Digital Health; Regulatory Relief/Waivers; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs

LobbyistCovered position, as disclosed
MEGHAN CLUNE WOLTMAN —
ANTHONY CURRY —
SHAUNA GARDNER —
JOYCE ROGERS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2150 (116th), H.R. 1499 (116th), H.R. 987 (116th), H.R. 1897 (116th), S. 916 (116th), H.R. 2753 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.